(Q31437280)

2 July 2017

title

Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function (English)

1 reference

2 July 2017

0 references

1 reference

norethindrone enanthate

1 reference

Kamischke A

1

1 reference

2 July 2017

Diebäcker J

series ordinal

2

1 reference

2 July 2017

Nieschlag E

series ordinal

3

1 reference

2 July 2017

publication date

1 September 2000

1 reference

2 July 2017

published in

Clinical Endocrinology

1 reference

2 July 2017

volume

53

1 reference

2 July 2017

issue

3

1 reference

2 July 2017

page(s)

351-358

1 reference

Attainment and maintenance of azoospermia with combined monthly injections of depot medroxyprogesterone acetate and testosterone enanthate

2 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

Assessment of the specificity of norethisterone radioimmunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

Experience with external quality control in spermatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

Pharmacokinetics of once-a-month injectable contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

Endocrine, seminal and peripheral effects of depot medroxyprogesterone acetate and testosterone enanthate in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

Low dose of cyproterone acetate and testosterone enanthate for contraception in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

Induction of male sexual behavior by norethisterone: role of its A-ring reduced metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

Contraceptive efficacy of testosterone-induced azoospermia in normal men

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.01097.X

10.1046/J.1365-2265.2000.01097.X

21 January 2018

Identifiers

DOI

1 reference

2 July 2017

1 reference